Search details
1.
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity.
Nature
; 570(7761): E53, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-31142845
2.
Design of amidobenzimidazole STING receptor agonists with systemic activity.
Nature
; 564(7736): 439-443, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30405246
3.
Observation on the ice crystal formation process of large yellow croaker (Pseudosciaena crocea) and the effect of multiple cryoprotectants pre-soaking treatments on frozen quality.
Cryobiology
; 113: 104580, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37625476
4.
TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury.
Am J Physiol Lung Cell Mol Physiol
; 307(2): L158-72, 2014 Jul 15.
Article
in English
| MEDLINE | ID: mdl-24838754
5.
Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivity.
Bioorg Med Chem
; 21(4): 979-92, 2013 Feb 15.
Article
in English
| MEDLINE | ID: mdl-23294830
6.
Evaluation of GSK2789917-induced TRPV4 inhibition in animal models of fluid induced lung injury.
Naunyn Schmiedebergs Arch Pharmacol
; 2023 Nov 15.
Article
in English
| MEDLINE | ID: mdl-37966569
7.
Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions.
J Med Chem
; 63(23): 14867-14884, 2020 12 10.
Article
in English
| MEDLINE | ID: mdl-33201708
8.
Discovery of GSK2798745: A Clinical Candidate for Inhibition of Transient Receptor Potential Vanilloid 4 (TRPV4).
ACS Med Chem Lett
; 10(8): 1228-1233, 2019 Aug 08.
Article
in English
| MEDLINE | ID: mdl-31413810
9.
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4).
J Med Chem
; 61(21): 9738-9755, 2018 11 08.
Article
in English
| MEDLINE | ID: mdl-30335378
10.
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1.
ACS Med Chem Lett
; 9(7): 736-740, 2018 Jul 12.
Article
in English
| MEDLINE | ID: mdl-30034610
11.
Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors.
J Med Chem
; 50(1): 6-9, 2007 Jan 11.
Article
in English
| MEDLINE | ID: mdl-17201405
12.
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity.
J Med Chem
; 50(1): 2-5, 2007 Jan 11.
Article
in English
| MEDLINE | ID: mdl-17201404
13.
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4.
ACS Med Chem Lett
; 8(5): 549-554, 2017 May 11.
Article
in English
| MEDLINE | ID: mdl-28523109
14.
Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
J Med Chem
; 57(8): 3464-83, 2014 Apr 24.
Article
in English
| MEDLINE | ID: mdl-24670009
15.
An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.
Sci Transl Med
; 4(159): 159ra148, 2012 Nov 07.
Article
in English
| MEDLINE | ID: mdl-23136043
Results
1 -
15
de 15
1
Next >
>>